Vilon

Preclinical Research

Vilon (Lys-Glu)

A dipeptide bioregulator (Lys-Glu) researched for immune regulation, anti-aging, and cellular health. One of the simplest bioregulator peptides.

SubQ injectionOralImmune SupportLongevityAnti-Aging

Dose

100-500 mcg

Route

SubQ injection, Oral

Cycle

10-20 days

Storage

Refrigerated (2-8°C) away from light for up to 2 years.

What is Vilon?

Vilon is a synthetic dipeptide bioregulator, composed of L-lysine and L-glutamic acid. It is part of the class of bioregulator peptides, which are hypothesized to exert their effects by regulating gene expression and protein synthesis, particularly in conditions of stress or aging. Research indicates its potential roles in immune system modulation, cellular health support, and broader anti-aging processes. Due to its small size and simple structure, Vilon is often cited for its proposed ability to interact with cellular mechanisms to restore balance and function.

Key Benefits

  • Immune regulation
  • Cell health support
  • Anti-aging potential
  • Gene regulation
  • Simple structure with diverse effects

Mechanism of Action

  • Dipeptide bioregulator
  • Modulates gene expression
  • Immune cell regulation
  • May influence telomere biology

Best For

  • Longevity research
  • Immune research
  • Anti-aging

Body Systems

ImmuneCellular

🐾 Griffin Says...

Vilon is the simplest of the bioregulator peptides - just two amino acids. Simple doesn't mean weak though. It's part of the same Russian bioregulator research tradition as Epithalon and Thymalin, with a focus on immune regulation.

Molecular Information

Molecular weight

246.24 g/mol

Length

2

Type

Dipeptide bioregulator

Amino acid sequence

Lys-Glu

L-Lysine-L-Glutamic acid dipeptide

Research Indications

  • Immune System Modulation

    Research suggests Vilon may help normalize various parameters of cellular and humoral immunity, particularly in immune-compromised states.

  • Inflammation Regulation

    Studies indicate a potential role in modulating inflammatory responses, contributing to overall immune balance.

Research Protocols

GoalDoseFrequencyRoute
General Immune Support & Anti-Aging500 mcgOnce daily for 10 daysSubcutaneous injection
Enhanced Cellular Health250 mcgOnce daily for 20 daysSubcutaneous injection
Oral Administration for Maintenance1 mgOnce daily for 10-20 daysOral (sublingual or encapsulated)
Intensive Immune Support1 mgOnce daily for 10-15 daysSubcutaneous injection
Low-Dose Long-Term Cycling100-200 mcgOnce daily for 20 days, repeat every 4-6 monthsSubcutaneous injection

Vilon is typically administered in cycles, with a period of administration followed by a longer period of rest. This cycling approach is commonly discussed in research contexts for bioregulator peptides to optimize their long-term effects.

Peptide Interactions

  • Immunosuppressants

    Given Vilon's potential immune-modulating effects, concurrent use with immunosuppressive drugs should be approached with caution, as it may alter their efficacy. Further research is needed.

    Use Caution
  • Other Bioregulator Peptides

    While combinations of bioregulator peptides are sometimes explored in research, specific interactions with Vilon are not well-documented. Monitor for synergistic or additive effects.

    Monitor Combination
  • Antioxidants (e.g., Vitamin C, E)

    No known negative interactions. Antioxidants are generally considered compatible and may complement cellular health initiatives.

    Compatible
  • General Health Supplements

    Most common vitamins, minerals, and dietary supplements are unlikely to interact negatively with Vilon due to its specific mechanism of action.

    Compatible
  • Antibiotics

    No direct contraindications are noted; however, individuals undergoing acute infection treatment should consult with research literature regarding immune support strategies.

    Compatible

How to Reconstitute

  1. 1Gather materials: Vilon vial, bacteriostatic water (or sterile water), mixing syringe (e.g., 1mL), insulin syringe for dosing, alcohol wipes.
  2. 2Wipe the rubber stopper of the Vilon vial and the bacteriostatic water vial with alcohol wipes.
  3. 3Draw the desired amount of bacteriostatic water into the mixing syringe. A common ratio is 1-2 mL per 5-10 mg vial to achieve a manageable concentration.
  4. 4Slowly inject the bacteriostatic water into the Vilon vial, aiming the stream towards the glass wall, not directly onto the lyophilized powder, to avoid foaming.
  5. 5Remove the mixing syringe and gently swirl the vial (do not shake vigorously) until the powder is completely dissolved. This may take a few minutes.
  6. 6Once fully dissolved, the solution should be clear. Store the reconstituted Vilon in the refrigerator.

Bacteriostatic water is commonly discussed for reconstitution to inhibit bacterial growth, extending the shelf life of the reconstituted solution. Sterile water for injection is an alternative for immediate use.

What to Expect

  • Weeks 1-2: Some individuals report initial subtle improvements in overall well-being or energy. For others, this period may pass without noticeable changes.
  • Weeks 3-4 (through end of cycle): More pronounced effects related to immune function or general vitality may begin to emerge. These effects are often gradual.
  • Months 1-3 (post-cycle): The long-term effects of the cycle are hypothesized to develop during this period, even without active administration.
  • Months 4-6 (pre-next cycle): Benefits from the previous cycle are expected to stabilize, and individuals may consider initiating a new cycle based on research protocols.
  • Long-term use (multiple cycles): Continued benefits in immune regulation and cellular health are discussed, consistent with the bioregulator hypothesis, though individual responses vary.

Side Effects & Safety

EffectFrequencySeverity
Minimal reportedRareMild

Ready to calculate your dose? Use Griffin's Peptide Calculator 🐾

Open Calculator

Peptides discussed here are for research purposes only. Nothing on this page is medical advice. Always consult a qualified professional before making health decisions.